The Precision Peptide CoPNGAF -1.93%21 Market Cap is $15.08 Mil as of Jun. 27, 2026. GuruFocus rates PNGAF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 2,041 Consumer Packaged Goods companies, The Precision Peptide Co ranks worse than 78.88% on this metric.
The Precision Peptide Co's quarterly market cap
increased
from Jul. 2025 ($6.51 Mil) to Oct. 2025 ($11.71 Mil) but then
declined
from Oct. 2025 ($11.71 Mil) to Jan. 2026 ($7.29 Mil).
The Precision Peptide Co's annual market cap
declined
from Oct. 2023 ($3.71 Mil) to Oct. 2024 ($1.48 Mil) but then
increased
from Oct. 2024 ($1.48 Mil) to Oct. 2025 ($11.71 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. The Precision Peptide Co's Enterprise Value for Today is $14.98 Mil.
The Precision Peptide Co (OTCPK:PNGAF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
The Precision Peptide Co Market Cap Related Terms
The Precision Peptide Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, The Precision Peptide Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Precision Peptide Co Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, The Precision Peptide Co's Market Cap distribution charts can be found below:
* The bar in red indicates where The Precision Peptide Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
The Precision Peptide Co's Market Cap for the fiscal year that ended in Oct. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Precision Peptide Co (PNGAF) has a Market Cap of $15.08 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on The Precision Peptide Co and its competitors. According to the industry distribution chart, The Precision Peptide Co ranks #1610 out of 2041 companies in the Consumer Packaged Goods industry, placing it in the top 78.9%.
Is The Precision Peptide Co's Market Cap too high?
The Precision Peptide Co's current Market Cap is $15.08 Mil. The Consumer Packaged Goods industry median Market Cap is 100.76. The Precision Peptide Co's value of $15.08 Mil is 85% below this industry median. Based on the distribution chart, The Precision Peptide Co ranks #1610 out of 2041 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, The Precision Peptide Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's Market Cap compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, The Precision Peptide Co ranks #1610 out of 2041 companies for Market Cap. This places The Precision Peptide Co in the lower half of its industry. The industry median Market Cap is 100.76. The Precision Peptide Co's value of $15.08 Mil is 85% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 100.76, based on 2,041 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Precision Peptide Co's current Market Cap of $15.08 Mil is 85% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on The Precision Peptide Co and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 100.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Precision Peptide Co's current Market Cap is $15.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current Market Cap of $15.08 Mil. The current Market Cap is $15.08 Mil and 85% below the Consumer Packaged Goods industry median of 100.76. The Precision Peptide Co's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current Market Cap is $15.08 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
21GF Score
Get the complete analysis for PNGAF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNGAF has been successfully added to your 
